Michigan Legislative Activity Ledger

Script-free record · Release 2026-07-28.3

Committee vote · not_prevailed · 12–16–1

Core facts and links below come from the same immutable public release as the enhanced record page.

committee vote

Recorded committee decision

to adopt the amendments to SB 690(H-1).

Meeting date
Not recorded
Result
not prevailed
Yeas
12
Nays
16
Validation
consistent
Related meeting
meeting-2433

A committee motion is a proceeding-level decision. A named choice supports that individual vote only and does not establish continuous attendance.

Inspect all published fields
Canonical name
Joseph Tate
Committee vote id
committee-vote-271367
Evidence text
Representative Tate moved to adopt the amendments to SB 690(H-1). The motion did not prevail 12-16-1: UNFAVORABLE ROLL CALL Yeas: Reps. Hoadley, Love, Pagan, Hammoud, Peterson, Sabo, Anthony, Brixie, Cherry, Hood, Kennedy, Tate. Nays: Reps. Hernandez, Miller, Sheppard, Albert, Allor, Brann, VanSingel, Whiteford, Yaroch, Bollin, Green, Huizenga, Lightner, Maddock, Slagh, VanWoerkom. Pass: Rep. Glenn. Representative Hoadley offered the following amendments to SB 690 (H-1): 1. Amend page 4, following line 22, by inserting: “Testing capacity grant program............................................................................ 5,000,000”. 2. Amend page 4, line 26, by striking out "750,000,000" and inserting "755,000,000" and adjusting the subtotals, totals, and section 201 accordingly. 3. Amend page 18, following line 20, by inserting: “Sec. 506. (1) From the funds appropriated in part 1 for the testing capacity grant program, the Michigan strategic fund shall develop a testing capacity grant program that would provide grants for COVID-19 or antibody testing to assist in scaling up testing capacity. (2) Grants under the program must not exceed $1,000,000.00 per grant recipient. (3) Priority should be given to those applicants who have not received assistance from the federal paycheck protection program, federal small business administration programs developed in response to COVID-19, or Michigan economic development corporation and Michigan strategic fund programs developed in response to COVID-19. (4) Grant funding made available under the program must be used for one or more of the following: (a) Hiring of laboratory and administrative support staff. (b) Upgrading software for automated reporting to the state database. (c) Training and resources for pharmacy collection. (d) Purchasing inventory necessary for testing including, but not limited to, reagents, personal protection equipment, and consumables.”.
Meeting id
meeting-2433
Member id
member-103
Motion text
to adopt the amendments to SB 690(H-1).
Mover label
Tate
Nays
16
Passes
1
Position
7
Resolution method
unique surname
Result
not prevailed
Service id
service-452
Validation state
consistent
Yeas
12

Follow the evidence

Cite this record

Michigan Legislative Activity and Evidence Dataset, release 2026-07-28.3, “Committee vote · not_prevailed · 12–16–1,” /committee-votes/committee-vote-271367.

/api/v1/committee-votes/committee-vote-271367